Header Logo

James Mulshine

Concepts (708)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lung Neoplasms
176
2023
507
18.450
Why?
Tomography, X-Ray Computed
34
2021
723
5.570
Why?
Mass Screening
35
2023
166
4.910
Why?
Early Detection of Cancer
15
2023
85
4.170
Why?
Carcinoma, Non-Small-Cell Lung
46
2016
218
3.010
Why?
Tomography, Spiral Computed
17
2014
27
2.330
Why?
Carcinoma, Small Cell
45
2005
54
2.120
Why?
Biomarkers, Tumor
30
2010
179
1.850
Why?
Humans
212
2023
26257
1.820
Why?
Pulmonary Disease, Chronic Obstructive
3
2021
49
1.710
Why?
Antibodies, Monoclonal
40
1999
192
1.470
Why?
Neoplasms
12
2017
221
1.360
Why?
Smoking
17
2015
170
1.340
Why?
Algorithms
5
2020
363
1.170
Why?
Image Processing, Computer-Assisted
3
2020
187
1.090
Why?
Emphysema
2
2023
4
1.080
Why?
Lung
12
2023
155
1.070
Why?
Drug Design
6
2013
22
1.060
Why?
Antineoplastic Agents
12
2016
176
1.010
Why?
Drug Delivery Systems
6
2009
29
1.000
Why?
Smoking Cessation
7
2014
47
0.990
Why?
Diagnostic Imaging
4
2017
72
0.970
Why?
Multiple Pulmonary Nodules
2
2014
11
0.960
Why?
Tumor Cells, Cultured
43
2005
116
0.940
Why?
Heterogeneous-Nuclear Ribonucleoprotein Group A-B
9
2010
9
0.920
Why?
Peptides
20
1997
97
0.880
Why?
Pulmonary Emphysema
1
2023
2
0.870
Why?
Practice Guidelines as Topic
5
2020
294
0.850
Why?
Solitary Pulmonary Nodule
2
2015
13
0.830
Why?
Gene Expression Regulation, Neoplastic
9
2010
95
0.820
Why?
Anticarcinogenic Agents
8
2005
16
0.800
Why?
Neoplasm Proteins
8
2007
51
0.790
Why?
Breast Neoplasms
11
2015
353
0.760
Why?
Growth Substances
15
1996
31
0.750
Why?
Cell Transformation, Neoplastic
7
2003
32
0.690
Why?
Sputum
14
2005
21
0.690
Why?
Arachidonic Acid
5
2005
13
0.680
Why?
Leukoplakia, Oral
2
2013
3
0.670
Why?
Lipoxygenase Inhibitors
6
2006
7
0.650
Why?
Smoking Prevention
4
2014
16
0.640
Why?
Occupational Exposure
2
2018
17
0.640
Why?
Systems Biology
1
2018
6
0.630
Why?
Occupational Diseases
1
2018
16
0.630
Why?
Radiation Exposure
1
2018
9
0.630
Why?
Neoplasms, Radiation-Induced
1
2018
11
0.630
Why?
United States
16
2018
1989
0.620
Why?
Tobacco Use Disorder
1
2018
17
0.620
Why?
Myocardial Ischemia
1
2018
42
0.600
Why?
Gene Expression Profiling
3
2007
125
0.590
Why?
Radiographic Image Enhancement
2
2015
27
0.570
Why?
Health Policy
2
2015
49
0.560
Why?
Cell Division
22
2003
79
0.550
Why?
Thoracic Surgery, Video-Assisted
2
2015
18
0.540
Why?
Sensitivity and Specificity
13
2016
483
0.530
Why?
DNA-Binding Proteins
8
2003
254
0.520
Why?
Genes, ras
8
2003
12
0.520
Why?
Reproducibility of Results
9
2020
677
0.520
Why?
Imaging, Three-Dimensional
2
2014
217
0.510
Why?
Gastrin-Releasing Peptide
18
1999
18
0.510
Why?
Actuarial Analysis
3
2012
6
0.510
Why?
Mesoderm
3
2010
19
0.480
Why?
Pneumonectomy
2
2015
67
0.480
Why?
Oligonucleotide Array Sequence Analysis
4
2007
49
0.470
Why?
Cyclooxygenase Inhibitors
4
2004
26
0.470
Why?
Publishing
1
2014
36
0.470
Why?
United States Dept. of Health and Human Services
1
2014
3
0.460
Why?
Tobacco Smoke Pollution
1
2014
6
0.460
Why?
Neoplasm Staging
15
2008
314
0.460
Why?
Growth Inhibitors
6
1999
11
0.460
Why?
Animals
36
2010
3386
0.460
Why?
Transcription Factors
3
2010
159
0.460
Why?
Female
45
2018
14516
0.460
Why?
Indoles
5
2006
34
0.450
Why?
Carcinoma, Squamous Cell
5
2013
160
0.440
Why?
Trypsin Inhibitor, Bowman-Birk Soybean
1
2013
1
0.440
Why?
Trypsin Inhibitors
1
2013
2
0.440
Why?
Genome, Human
1
2013
41
0.430
Why?
Inflammation
3
2009
265
0.410
Why?
Bronchoalveolar Lavage Fluid
4
1997
13
0.410
Why?
Male
38
2018
14123
0.410
Why?
Radiation Dosage
8
2017
36
0.410
Why?
Image Interpretation, Computer-Assisted
3
2009
69
0.410
Why?
Prostaglandin-Endoperoxide Synthases
4
2003
25
0.410
Why?
Insurance Benefits
1
2012
1
0.400
Why?
Oropharyngeal Neoplasms
2
2004
20
0.400
Why?
Cost Savings
1
2012
30
0.400
Why?
Medical Oncology
5
2014
40
0.380
Why?
Bombesin
10
1997
10
0.380
Why?
Heterogeneous-Nuclear Ribonucleoproteins
2
2009
2
0.380
Why?
Epithelium
3
2010
23
0.370
Why?
RNA, Messenger
15
2005
264
0.370
Why?
Isotretinoin
6
2005
8
0.370
Why?
Antineoplastic Combined Chemotherapy Protocols
9
2006
224
0.370
Why?
Precancerous Conditions
5
2004
21
0.360
Why?
Spirometry
1
2010
11
0.350
Why?
Diagnosis, Computer-Assisted
1
2010
18
0.350
Why?
Proportional Hazards Models
4
2010
326
0.350
Why?
Hyaluronic Acid
1
2010
54
0.340
Why?
Intercellular Signaling Peptides and Proteins
1
2010
53
0.340
Why?
Chemokines
1
2009
21
0.330
Why?
Epithelial Cells
5
2010
76
0.330
Why?
Cost-Benefit Analysis
5
2014
126
0.320
Why?
Inflammation Mediators
1
2009
58
0.320
Why?
Cytokines
1
2010
226
0.320
Why?
Risk Factors
12
2014
2265
0.310
Why?
Arachidonate 5-Lipoxygenase
2
1999
6
0.300
Why?
Drug Approval
1
2007
7
0.300
Why?
Middle Aged
28
2018
8599
0.290
Why?
Cell Line, Tumor
4
2010
231
0.290
Why?
Signal Transduction
6
2006
385
0.290
Why?
Immunohistochemistry
11
2005
337
0.290
Why?
Retinoids
2
2005
4
0.280
Why?
Risk Assessment
7
2014
629
0.280
Why?
Mice
20
2000
1277
0.280
Why?
Multienzyme Complexes
4
1999
25
0.280
Why?
Antigens, Neoplasm
11
1994
38
0.280
Why?
Indium Radioisotopes
4
1999
5
0.280
Why?
Ketorolac
2
2004
12
0.270
Why?
Transcription, Genetic
3
2006
91
0.270
Why?
Apoptosis
3
2005
193
0.270
Why?
Chemoprevention
2
2003
4
0.260
Why?
Time Factors
8
2014
1382
0.260
Why?
Radiographic Image Interpretation, Computer-Assisted
4
2017
29
0.260
Why?
Software
3
2014
64
0.260
Why?
Anti-Inflammatory Agents, Non-Steroidal
3
2004
98
0.260
Why?
Biomarkers
8
2021
556
0.260
Why?
Prostaglandin D2
1
2005
2
0.250
Why?
Peroxisome Proliferator-Activated Receptors
1
2005
3
0.250
Why?
Head and Neck Neoplasms
2
2005
141
0.250
Why?
Clinical Trials as Topic
9
2006
215
0.250
Why?
DNA Mutational Analysis
2
2003
49
0.250
Why?
Prognosis
11
2005
758
0.230
Why?
Transferrin
3
1996
6
0.230
Why?
Patient Selection
3
2020
194
0.230
Why?
Mass Chest X-Ray
1
2003
1
0.220
Why?
Insulin-Like Growth Factor I
8
2001
52
0.220
Why?
Neoplasms, Second Primary
4
1997
33
0.220
Why?
Carrier Proteins
3
1999
79
0.220
Why?
Cell Hypoxia
1
2003
9
0.210
Why?
Isoenzymes
3
2000
45
0.210
Why?
Proto-Oncogene Proteins p21(ras)
1
2003
17
0.210
Why?
Adenocarcinoma
7
1998
123
0.210
Why?
Neoplasm Invasiveness
4
2010
77
0.210
Why?
Down-Regulation
1
2003
92
0.210
Why?
Survival Rate
6
2016
322
0.200
Why?
Thoracic Surgical Procedures
2
2012
8
0.200
Why?
Nuclear Proteins
4
2010
80
0.200
Why?
Quality Assurance, Health Care
2
2017
38
0.190
Why?
Hydroxyeicosatetraenoic Acids
1
2001
1
0.190
Why?
Receptors, Cytoplasmic and Nuclear
1
2001
20
0.190
Why?
Molecular Sequence Data
16
1996
162
0.190
Why?
Mixed Function Oxygenases
4
1999
4
0.190
Why?
Ribonucleoproteins, Small Nuclear
1
2000
2
0.180
Why?
Membrane Proteins
2
1999
151
0.180
Why?
Disease Management
1
2001
109
0.180
Why?
Carcinoma
2
1999
60
0.180
Why?
Databases, Factual
2
2006
333
0.180
Why?
National Institutes of Health (U.S.)
3
1996
23
0.180
Why?
Interleukin-6
1
2000
72
0.180
Why?
Radioimmunodetection
1
1999
1
0.170
Why?
Aged
19
2018
8763
0.170
Why?
Polymerase Chain Reaction
8
2003
106
0.170
Why?
Advisory Committees
3
2014
22
0.160
Why?
Nuclear Weapons
1
2018
1
0.160
Why?
Pancreatic Neoplasms
2
1993
67
0.160
Why?
Pandemics
1
2021
238
0.160
Why?
Gene Expression Regulation, Developmental
1
1998
28
0.160
Why?
Oncogenes
7
1994
11
0.160
Why?
Genetic Markers
2
2000
34
0.160
Why?
Dose-Response Relationship, Drug
7
2005
315
0.150
Why?
Cell Growth Processes
2
2010
6
0.150
Why?
Receptors, Transferrin
2
1996
4
0.150
Why?
History, 21st Century
2
2017
23
0.150
Why?
Retinoblastoma Protein
2
1995
10
0.150
Why?
Thoracic Neoplasms
2
2017
8
0.150
Why?
Blotting, Northern
6
2003
20
0.150
Why?
Randomized Controlled Trials as Topic
3
2005
311
0.150
Why?
Data Mining
1
2017
3
0.150
Why?
Information Dissemination
1
2017
17
0.150
Why?
Microscopy
1
1997
10
0.150
Why?
Early Diagnosis
1
2017
65
0.140
Why?
Lymphoma
4
1991
36
0.140
Why?
Adult
15
2018
7447
0.140
Why?
Point Mutation
1
1997
27
0.140
Why?
Amino Acid Sequence
12
1996
132
0.140
Why?
Radioimmunoassay
6
1993
11
0.140
Why?
Amidine-Lyases
2
1993
2
0.140
Why?
Neoplasm Metastasis
3
2004
93
0.130
Why?
Gallium
1
1996
3
0.130
Why?
Biological Specimen Banks
1
1996
6
0.130
Why?
Military Medicine
1
1996
8
0.130
Why?
Mice, Inbred BALB C
6
2000
97
0.130
Why?
Combined Modality Therapy
9
2016
281
0.130
Why?
Protein Processing, Post-Translational
5
1993
33
0.130
Why?
Vascular Calcification
1
2015
9
0.120
Why?
Coronary Vessels
1
2015
31
0.120
Why?
Base Sequence
7
2003
89
0.120
Why?
RNA, Neoplasm
7
1999
12
0.120
Why?
Immunoglobulin G
4
1999
87
0.120
Why?
Carcinoma, Intraductal, Noninfiltrating
2
2005
9
0.120
Why?
Skin Neoplasms
3
1991
67
0.120
Why?
Lyases
2
1993
8
0.120
Why?
Mesothelioma
1
1994
11
0.120
Why?
Mutation
5
2016
314
0.120
Why?
Mice, Nude
8
1998
23
0.120
Why?
Physicians, Primary Care
1
2014
6
0.120
Why?
Physician's Role
1
2014
17
0.120
Why?
Electronic Nicotine Delivery Systems
1
2014
2
0.120
Why?
International Agencies
1
2014
4
0.120
Why?
History, 20th Century
1
2014
45
0.110
Why?
Data Collection
2
2013
91
0.110
Why?
Lymph Nodes
4
1991
62
0.110
Why?
Forecasting
1
2014
89
0.110
Why?
Tobacco Use Cessation
1
2013
1
0.110
Why?
Neuroendocrine Tumors
1
1993
21
0.110
Why?
Congresses as Topic
1
2013
29
0.110
Why?
Ligands
2
2005
39
0.110
Why?
Tobacco Use
1
2013
7
0.110
Why?
Cell Movement
2
2010
77
0.110
Why?
DNA Primers
4
2003
45
0.110
Why?
Phenotype
2
2010
289
0.110
Why?
Incidence
3
2010
716
0.110
Why?
Evidence-Based Medicine
1
2014
186
0.110
Why?
Radiography, Thoracic
2
2005
22
0.110
Why?
ErbB Receptors
2
2010
51
0.110
Why?
Antigens, Surface
5
1986
13
0.110
Why?
Neuropeptides
2
1995
29
0.100
Why?
International Cooperation
2
2002
22
0.100
Why?
Genes, Tumor Suppressor
3
2000
10
0.100
Why?
Eicosanoids
2
2003
2
0.100
Why?
Codon
4
2003
5
0.100
Why?
Patient Education as Topic
2
2005
140
0.100
Why?
Drug Screening Assays, Antitumor
4
1999
10
0.100
Why?
Practice Patterns, Physicians'
1
2013
104
0.100
Why?
Protein Binding
2
2009
113
0.100
Why?
Research
1
1992
35
0.100
Why?
Artificial Intelligence
2
2023
26
0.100
Why?
Receptors, Retinoic Acid
3
2000
3
0.100
Why?
Immunoenzyme Techniques
6
1998
30
0.100
Why?
Microsatellite Repeats
2
2001
10
0.100
Why?
Aerosols
2
2002
21
0.090
Why?
Twist-Related Protein 1
1
2010
3
0.090
Why?
Snail Family Transcription Factors
1
2010
5
0.090
Why?
Laminin
1
1990
8
0.090
Why?
Basement Membrane
1
1990
11
0.090
Why?
Gene Silencing
1
2010
19
0.090
Why?
Oligopeptides
1
1990
22
0.090
Why?
Organoplatinum Compounds
1
1990
2
0.090
Why?
Cadherins
1
2010
34
0.090
Why?
Matrix Metalloproteinase 2
1
2010
3
0.090
Why?
Spain
1
2010
9
0.090
Why?
Matrix Metalloproteinase 9
1
2010
7
0.090
Why?
Glucuronosyltransferase
1
2010
4
0.090
Why?
Hyaluronan Synthases
1
2010
5
0.090
Why?
Transforming Growth Factor beta1
1
2010
20
0.090
Why?
Interleukin-1beta
1
2010
51
0.090
Why?
Age Distribution
1
2010
81
0.090
Why?
Sex Distribution
1
2010
76
0.090
Why?
Blotting, Western
4
2006
133
0.090
Why?
Protein Kinase Inhibitors
1
2010
45
0.090
Why?
DNA, Neoplasm
5
1998
16
0.090
Why?
Hyperplasia
2
2000
14
0.090
Why?
Drug Resistance
5
1994
42
0.080
Why?
Cell Line
13
1992
244
0.080
Why?
Mice, Inbred A
2
2000
2
0.080
Why?
Quality of Life
1
2014
621
0.080
Why?
Disease Progression
4
2008
685
0.080
Why?
Neoplasm Recurrence, Local
2
2006
186
0.080
Why?
Diagnosis, Differential
4
2006
347
0.080
Why?
Tissue Distribution
9
1998
25
0.080
Why?
Cytodiagnosis
3
1993
19
0.080
Why?
Prospective Studies
6
2008
1668
0.080
Why?
Etoposide
6
1996
25
0.080
Why?
Prevalence
1
2010
437
0.080
Why?
Gastrins
3
1993
3
0.080
Why?
Cisplatin
6
1996
47
0.080
Why?
Gene Deletion
2
2000
31
0.080
Why?
Liver Neoplasms
3
1990
91
0.080
Why?
Decision Making
2
2017
223
0.080
Why?
Radionuclide Imaging
7
1991
42
0.070
Why?
5-Lipoxygenase-Activating Proteins
2
1999
2
0.070
Why?
Drug Therapy, Computer-Assisted
1
2007
4
0.070
Why?
Gene Targeting
1
2007
10
0.070
Why?
Prostatic Neoplasms
2
1999
88
0.070
Why?
Radiology Information Systems
1
2007
2
0.070
Why?
Regression Analysis
1
1988
253
0.070
Why?
Clinical Trials, Phase II as Topic
2
2000
21
0.070
Why?
United States Food and Drug Administration
1
2007
22
0.070
Why?
Models, Biological
3
2004
301
0.070
Why?
Medical Laboratory Science
1
2007
8
0.070
Why?
Societies, Medical
3
2013
146
0.070
Why?
Pulmonary Surfactants
3
1992
5
0.070
Why?
Proteolipids
3
1992
6
0.070
Why?
Masoprocol
2
1998
6
0.070
Why?
Carcinogens
2
2000
8
0.070
Why?
Radiography
1
2009
616
0.070
Why?
Genes, p53
2
2000
15
0.070
Why?
Adenocarcinoma, Bronchiolo-Alveolar
1
2006
2
0.070
Why?
Age Factors
4
2012
751
0.070
Why?
Histiocytes
1
1986
4
0.070
Why?
Granulocytes
1
1986
15
0.070
Why?
Hodgkin Disease
1
1986
16
0.070
Why?
Europe
1
2006
66
0.070
Why?
Actins
1
2006
35
0.070
Why?
Cytoskeleton
1
2006
38
0.070
Why?
Microscopy, Confocal
1
2006
85
0.060
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2006
119
0.060
Why?
Iodine Radioisotopes
3
1993
8
0.060
Why?
Culture Media, Conditioned
3
2000
16
0.060
Why?
Acetophenones
1
2005
1
0.060
Why?
Tetrazoles
1
2005
2
0.060
Why?
Retinoid X Receptor alpha
1
2005
5
0.060
Why?
Thiazolidinediones
1
2005
7
0.060
Why?
Caspases
1
2005
26
0.060
Why?
Pyrimidines
1
2005
20
0.060
Why?
Bronchoalveolar Lavage
2
2003
3
0.060
Why?
Ligases
2
2003
8
0.060
Why?
HeLa Cells
2
2003
39
0.060
Why?
Liver
3
2000
123
0.060
Why?
Enzyme Activation
1
2005
103
0.060
Why?
Patient Care Planning
1
2005
51
0.060
Why?
Apudoma
1
1984
1
0.060
Why?
Chemistry, Pharmaceutical
1
2004
4
0.060
Why?
von Hippel-Lindau Disease
1
1984
3
0.060
Why?
Pheochromocytoma
1
1984
5
0.060
Why?
Angiomatosis
1
1984
3
0.060
Why?
Binding Sites, Antibody
2
1983
3
0.060
Why?
Spectrum Analysis
1
2004
8
0.060
Why?
Mouth Mucosa
1
2004
10
0.060
Why?
Mouth Neoplasms
1
2004
19
0.060
Why?
Mouthwashes
1
2004
6
0.060
Why?
Cell Proliferation
1
2005
162
0.060
Why?
Chemotherapy, Adjuvant
4
2005
70
0.060
Why?
Placebos
1
2004
66
0.060
Why?
Proteins
2
1996
54
0.060
Why?
Rats
5
2000
596
0.060
Why?
Protein Precursors
5
1996
18
0.060
Why?
Administration, Inhalation
2
2000
29
0.060
Why?
Glycoproteins
3
1992
47
0.060
Why?
Endpoint Determination
1
2003
20
0.060
Why?
Dinoprostone
2
2000
15
0.050
Why?
Neovascularization, Pathologic
1
2003
33
0.050
Why?
Immunotherapy
3
2016
48
0.050
Why?
Hypoxia-Inducible Factor 1
1
2003
1
0.050
Why?
Tobacco Industry
1
2002
2
0.050
Why?
Hypoxia-Inducible Factor 1, alpha Subunit
1
2003
9
0.050
Why?
NF-kappa B
1
2003
108
0.050
Why?
Indium
3
1987
8
0.050
Why?
Enzyme Induction
2
2000
16
0.050
Why?
Double-Blind Method
1
2004
400
0.050
Why?
Radioisotopes
3
1987
10
0.050
Why?
Somatomedins
2
1996
4
0.050
Why?
Oxidative Stress
1
2003
97
0.050
Why?
Amides
3
1998
16
0.050
Why?
Anti-Inflammatory Agents
1
2003
75
0.050
Why?
Culture Media
2
1996
27
0.050
Why?
Neoplasm Transplantation
3
1998
13
0.050
Why?
Carboplatin
2
1994
23
0.050
Why?
Canada
2
2012
49
0.050
Why?
Genetic Therapy
1
2002
80
0.050
Why?
Survival Analysis
5
2010
235
0.050
Why?
Proteomics
1
2002
90
0.050
Why?
Population Surveillance
2
2012
101
0.050
Why?
bcl-2-Associated X Protein
1
2001
13
0.050
Why?
Cytoplasmic Granules
2
1993
5
0.050
Why?
Proto-Oncogene Proteins c-bcl-2
1
2001
20
0.050
Why?
Respiratory System
2
1992
7
0.050
Why?
Rats, Sprague-Dawley
2
2000
318
0.050
Why?
Receptors, Neurotransmitter
3
1991
6
0.050
Why?
Proto-Oncogene Proteins
1
2001
29
0.050
Why?
Tumor Stem Cell Assay
4
1999
4
0.050
Why?
Public Health
1
2001
62
0.050
Why?
Predictive Value of Tests
3
1997
459
0.050
Why?
Biopsy
3
2012
200
0.050
Why?
Ribonucleoproteins
1
2000
3
0.050
Why?
Binding Sites
2
1993
65
0.050
Why?
Immunologic Tests
1
2000
2
0.050
Why?
Drug Evaluation
3
1990
20
0.050
Why?
Methylation
1
2000
6
0.050
Why?
Loss of Heterozygosity
1
2000
5
0.050
Why?
Blood Platelets
1
1981
38
0.050
Why?
Receptors, Interleukin-6
1
2000
3
0.050
Why?
HL-60 Cells
1
2000
13
0.050
Why?
Comorbidity
2
2012
475
0.050
Why?
Granulocyte-Macrophage Colony-Stimulating Factor
1
2000
10
0.050
Why?
Paracrine Communication
1
2000
4
0.050
Why?
Tetradecanoylphorbol Acetate
1
2000
32
0.040
Why?
Trans-Activators
1
2000
22
0.040
Why?
Interleukin-8
1
2000
17
0.040
Why?
STAT3 Transcription Factor
1
2000
12
0.040
Why?
Particle Size
1
2000
51
0.040
Why?
Interleukin-1
1
2000
46
0.040
Why?
Antibodies
1
2000
41
0.040
Why?
RNA, Heterogeneous Nuclear
1
1999
1
0.040
Why?
Fetus
2
1998
32
0.040
Why?
Dogs
2
1991
176
0.040
Why?
Cyclooxygenase 1
1
1999
6
0.040
Why?
Injections, Subcutaneous
2
1991
22
0.040
Why?
Arachidonate 12-Lipoxygenase
1
1999
3
0.040
Why?
Cyclooxygenase 2
1
1999
27
0.040
Why?
Cyclooxygenase 2 Inhibitors
1
1999
23
0.040
Why?
Autocrine Communication
1
1999
2
0.040
Why?
Gene Expression Regulation
1
2000
234
0.040
Why?
Cinnamates
1
1999
8
0.040
Why?
Pilot Projects
1
2000
378
0.040
Why?
CD5 Antigens
1
1998
1
0.040
Why?
Colonic Neoplasms
1
1999
51
0.040
Why?
Immunoconjugates
1
1998
7
0.040
Why?
Lymphoma, T-Cell, Cutaneous
1
1998
7
0.040
Why?
Yttrium Radioisotopes
1
1998
9
0.040
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
1998
15
0.040
Why?
Capillaries
1
1998
11
0.040
Why?
Mammals
1
1998
22
0.040
Why?
Pregnancy
2
1998
311
0.040
Why?
Pyridines
1
1998
36
0.040
Why?
Lipoxygenase
1
1998
1
0.040
Why?
Benzoquinones
1
1998
2
0.040
Why?
Quinolines
1
1998
6
0.040
Why?
Bronchi
1
1998
11
0.040
Why?
Insulin-Like Growth Factor II
2
1996
8
0.040
Why?
Lung Diseases
1
1998
44
0.040
Why?
Stimulation, Chemical
2
2000
8
0.040
Why?
Cell Differentiation
4
1992
124
0.040
Why?
Glycolipids
3
1986
3
0.040
Why?
Remission Induction
3
1996
89
0.040
Why?
Gene Expression
2
1996
180
0.040
Why?
Lupus Erythematosus, Systemic
1
1981
191
0.040
Why?
Nurse-Patient Relations
1
2017
34
0.040
Why?
beta Carotene
1
1997
6
0.040
Why?
Physician-Patient Relations
1
2017
37
0.040
Why?
Neoplastic Stem Cells
2
1994
6
0.040
Why?
Follow-Up Studies
3
2006
1738
0.040
Why?
Positron-Emission Tomography
2
2008
84
0.030
Why?
Liver Function Tests
2
1988
19
0.030
Why?
In Vitro Techniques
3
1992
157
0.030
Why?
Diet
2
2000
170
0.030
Why?
Tomography, Emission-Computed
1
1996
9
0.030
Why?
Communication
1
2017
102
0.030
Why?
Electrophoresis, Polyacrylamide Gel
3
1996
24
0.030
Why?
Peptide Fragments
2
1996
74
0.030
Why?
Aminopterin
1
1996
1
0.030
Why?
Folic Acid Antagonists
1
1996
1
0.030
Why?
Dipyridamole
1
1996
2
0.030
Why?
Computer Communication Networks
1
1996
3
0.030
Why?
Maryland
1
1996
5
0.030
Why?
Receptor, IGF Type 1
1
1996
17
0.030
Why?
Transplantation, Heterologous
3
1990
16
0.030
Why?
Carcinoembryonic Antigen
2
1992
5
0.030
Why?
Molecular Biology
2
2007
11
0.030
Why?
Drug Resistance, Neoplasm
1
1996
61
0.030
Why?
Statistics, Nonparametric
2
2008
117
0.030
Why?
Antigens, Differentiation
1
1994
10
0.030
Why?
Cell Membrane
2
1993
82
0.030
Why?
Receptors, Estrogen
2
2005
57
0.030
Why?
Chromatography, Agarose
1
1993
2
0.030
Why?
Substrate Specificity
1
1993
19
0.030
Why?
Cattle
1
1993
117
0.030
Why?
Histocytochemistry
3
1992
14
0.030
Why?
Postoperative Care
1
1994
132
0.030
Why?
Preoperative Care
1
1994
122
0.030
Why?
Tumor Suppressor Protein p53
1
1994
80
0.030
Why?
Environmental Exposure
1
1993
10
0.030
Why?
Fluorodeoxyglucose F18
2
2008
38
0.030
Why?
Arginine Vasopressin
1
1993
2
0.030
Why?
Atrial Natriuretic Factor
1
1993
3
0.030
Why?
Inositol
1
1993
6
0.030
Why?
Cell Adhesion Molecules
1
1992
19
0.030
Why?
Mitogens
1
1992
5
0.030
Why?
Gastrointestinal Neoplasms
1
1992
20
0.030
Why?
Sodium
1
1993
60
0.030
Why?
Membrane Glycoproteins
1
1992
67
0.030
Why?
Severity of Illness Index
1
2016
936
0.030
Why?
Uteroglobin
1
1992
1
0.030
Why?
Carbohydrate Metabolism
1
1992
4
0.020
Why?
Hormones
1
1991
8
0.020
Why?
Chromogranins
2
1988
3
0.020
Why?
Gastric Acid
1
1991
8
0.020
Why?
Tamoxifen
1
1992
24
0.020
Why?
Adenoma
1
1992
43
0.020
Why?
Treatment Outcome
4
2006
3390
0.020
Why?
Antigens, Tumor-Associated, Carbohydrate
1
1991
1
0.020
Why?
Chromosome Aberrations
1
1991
13
0.020
Why?
Tretinoin
1
1991
14
0.020
Why?
Cluster Analysis
1
1991
38
0.020
Why?
Chromosome Disorders
1
1991
11
0.020
Why?
Retrospective Studies
2
1992
3366
0.020
Why?
Palliative Care
2
1996
103
0.020
Why?
Injections
1
1991
44
0.020
Why?
Peptides, Cyclic
1
1990
10
0.020
Why?
Cell Adhesion
1
1990
32
0.020
Why?
Insulin
2
1988
76
0.020
Why?
Up-Regulation
2
2001
149
0.020
Why?
Chromosome Deletion
2
1990
16
0.020
Why?
Tumor Burden
1
2010
19
0.020
Why?
Glycosphingolipids
1
1989
1
0.020
Why?
Confidence Intervals
1
2010
90
0.020
Why?
Mice, Transgenic
1
1990
200
0.020
Why?
SEER Program
1
2010
38
0.020
Why?
Models, Statistical
1
2010
122
0.020
Why?
Epidermal Growth Factor
1
1989
28
0.020
Why?
Mating Factor
1
1989
1
0.020
Why?
Chemistry
1
1989
1
0.020
Why?
Chemical Phenomena
1
1989
3
0.020
Why?
Saccharomyces cerevisiae
1
1989
18
0.020
Why?
Glutaral
1
1988
1
0.020
Why?
Polyvinyl Chloride
1
1988
1
0.020
Why?
Fixatives
1
1988
6
0.020
Why?
Registries
1
2010
177
0.020
Why?
Aromatic-L-Amino-Acid Decarboxylases
1
1988
1
0.020
Why?
Dopa Decarboxylase
1
1988
1
0.020
Why?
Neurosecretory Systems
1
1988
9
0.020
Why?
Random Allocation
1
1988
117
0.020
Why?
Antigen-Antibody Complex
3
1985
6
0.020
Why?
Tetrazolium Salts
1
1988
2
0.020
Why?
Spectrophotometry
1
1988
5
0.020
Why?
Selenium
1
1988
7
0.020
Why?
Thiazoles
1
1988
18
0.020
Why?
Receptors, Bombesin
4
1991
4
0.020
Why?
Thrombocytopenia
2
1994
21
0.020
Why?
Antibody Formation
1
1988
18
0.020
Why?
Models, Theoretical
1
1988
77
0.020
Why?
Estradiol
1
1988
37
0.020
Why?
Contrast Media
1
2008
60
0.020
Why?
Radiopharmaceuticals
1
2008
49
0.020
Why?
Databases, Protein
1
2007
1
0.020
Why?
Hydrocortisone
1
1988
38
0.020
Why?
Chi-Square Distribution
1
2008
134
0.020
Why?
Databases as Topic
1
2007
14
0.020
Why?
Pulmonary Surfactant-Associated Proteins
3
1992
3
0.020
Why?
Histocompatibility Antigens Class II
1
1987
6
0.020
Why?
Bronchoscopy
1
1987
28
0.020
Why?
Nerve Tissue Proteins
1
1988
149
0.020
Why?
Spleen
1
1987
31
0.020
Why?
Research Design
1
1988
183
0.020
Why?
Autoradiography
1
1986
6
0.020
Why?
Antigens, Differentiation, T-Lymphocyte
1
1986
3
0.020
Why?
Chromatography, High Pressure Liquid
2
1996
12
0.020
Why?
Vincristine
2
1996
21
0.020
Why?
Gene Amplification
1
1986
18
0.020
Why?
Cyclophosphamide
2
1996
49
0.020
Why?
Epitopes
3
1996
46
0.020
Why?
Methotrexate
2
1996
36
0.020
Why?
Doxorubicin
2
1996
54
0.020
Why?
beta 2-Microglobulin
1
1985
1
0.020
Why?
Radiotherapy, Adjuvant
1
2005
42
0.020
Why?
Avidin
1
1985
1
0.020
Why?
Ovalbumin
1
1985
6
0.020
Why?
Biotin
1
1985
7
0.020
Why?
HLA Antigens
1
1985
15
0.020
Why?
Ki-67 Antigen
1
2005
16
0.020
Why?
Pedigree
1
1984
55
0.020
Why?
Lewis X Antigen
1
1984
1
0.010
Why?
Stromal Cells
1
2005
31
0.010
Why?
Genes, Dominant
1
1984
10
0.010
Why?
Sulfur
1
1984
3
0.010
Why?
Oligosaccharides
1
1984
17
0.010
Why?
Technetium
1
1984
4
0.010
Why?
Technetium Tc 99m Sulfur Colloid
1
1984
8
0.010
Why?
Cell Survival
2
1998
111
0.010
Why?
Microscopy, Electron
2
1998
62
0.010
Why?
Scattering, Radiation
1
2004
36
0.010
Why?
Monte Carlo Method
1
2004
49
0.010
Why?
Carcinoma, Bronchogenic
1
1984
5
0.010
Why?
Antigen-Antibody Reactions
1
1983
5
0.010
Why?
Computer Simulation
1
2004
193
0.010
Why?
Immunoblotting
2
1996
55
0.010
Why?
Drug Synergism
2
1996
38
0.010
Why?
Brain Neoplasms
2
1996
76
0.010
Why?
Consensus Development Conferences as Topic
1
2002
4
0.010
Why?
Guidelines as Topic
1
2002
63
0.010
Why?
Rabbits
2
1996
180
0.010
Why?
Peptide Mapping
2
1996
5
0.010
Why?
Pulmonary Surfactant-Associated Protein A
2
1992
2
0.010
Why?
Prednisolone
1
1981
7
0.010
Why?
Platelet Count
1
1981
15
0.010
Why?
Azathioprine
1
1981
8
0.010
Why?
Plasmapheresis
1
1981
12
0.010
Why?
Methylprednisolone
1
1981
20
0.010
Why?
Mice, Inbred SENCAR
1
2000
1
0.010
Why?
Transglutaminases
1
2000
5
0.010
Why?
GTP-Binding Proteins
1
2000
10
0.010
Why?
Analysis of Variance
2
1991
252
0.010
Why?
Receptors, Cell Surface
2
1992
37
0.010
Why?
Ditiocarb
1
1999
1
0.010
Why?
Fatty Acids, Monounsaturated
1
1999
1
0.010
Why?
Hygromycin B
1
1999
2
0.010
Why?
Oligonucleotides, Antisense
1
1999
12
0.010
Why?
Transfection
1
1999
104
0.010
Why?
Radioimmunotherapy
1
1998
1
0.010
Why?
Lymphocyte Subsets
1
1998
7
0.010
Why?
Chromogranin A
2
1988
9
0.010
Why?
Cell Death
1
1998
43
0.010
Why?
Carbohydrate Sequence
2
1989
6
0.010
Why?
Proto-Oncogenes
2
1990
4
0.010
Why?
Mining
1
1997
1
0.010
Why?
Tin
1
1997
1
0.010
Why?
China
1
1997
50
0.010
Why?
Calcium
2
1991
366
0.010
Why?
Deoxyglucose
1
1996
2
0.010
Why?
Fluorine Radioisotopes
1
1996
5
0.010
Why?
Breast
1
1996
20
0.010
Why?
Cyanogen Bromide
1
1996
1
0.010
Why?
Chromatography, Ion Exchange
1
1996
6
0.010
Why?
T-Lymphocytes
2
1987
90
0.010
Why?
Phantoms, Imaging
1
1996
36
0.010
Why?
Anti-Bacterial Agents
1
1999
339
0.010
Why?
Cranial Irradiation
1
1996
11
0.010
Why?
Mammography
1
1996
47
0.010
Why?
Lomustine
1
1996
1
0.010
Why?
Mechlorethamine
1
1996
1
0.010
Why?
Nucleosides
1
1996
2
0.010
Why?
Sequence Analysis
1
1996
3
0.010
Why?
Carmustine
1
1996
2
0.010
Why?
Thymidine
1
1996
7
0.010
Why?
Immune Sera
1
1996
5
0.010
Why?
Depression, Chemical
1
1996
5
0.010
Why?
Proteasome Endopeptidase Complex
1
1996
13
0.010
Why?
Sequence Alignment
1
1996
15
0.010
Why?
Cross Reactions
1
1996
11
0.010
Why?
Antibody Specificity
1
1996
32
0.010
Why?
Biological Transport
1
1996
39
0.010
Why?
Evaluation Studies as Topic
1
1996
35
0.010
Why?
Radiotherapy Dosage
1
1996
93
0.010
Why?
Protein Conformation
1
1996
64
0.010
Why?
Cause of Death
1
1996
57
0.010
Why?
Specimen Handling
1
1996
40
0.010
Why?
Blotting, Southern
1
1995
3
0.010
Why?
Culture Media, Serum-Free
1
1995
6
0.010
Why?
Chromatography, Gel
1
1995
9
0.010
Why?
Cyclin-Dependent Kinase Inhibitor p16
1
1995
21
0.010
Why?
Homozygote
1
1995
18
0.010
Why?
Hemoglobins
1
1996
74
0.010
Why?
Triglycerides
1
1995
40
0.010
Why?
Serum Albumin
1
1995
21
0.010
Why?
Drug Therapy
1
1995
8
0.010
Why?
Leukopenia
1
1994
6
0.010
Why?
Proliferating Cell Nuclear Antigen
1
1994
8
0.010
Why?
Drug Administration Schedule
1
1994
156
0.010
Why?
Radiation Tolerance
1
1994
6
0.010
Why?
Adolescent
2
1994
2079
0.010
Why?
Clinical Trials, Phase III as Topic
1
1994
13
0.010
Why?
Radiotherapy
1
1994
32
0.010
Why?
Lymphatic Metastasis
1
1994
80
0.010
Why?
Weight Loss
1
1994
120
0.010
Why?
Ribonucleases
1
1993
7
0.010
Why?
Inappropriate ADH Syndrome
1
1993
2
0.010
Why?
Hyponatremia
1
1993
8
0.010
Why?
Antigens, CD
1
1992
51
0.010
Why?
Infant
1
1994
521
0.010
Why?
Child, Preschool
1
1994
593
0.010
Why?
Aged, 80 and over
1
2001
4674
0.010
Why?
Staining and Labeling
1
1992
15
0.010
Why?
Exons
1
1992
30
0.010
Why?
Infant, Newborn
1
1994
593
0.010
Why?
Glycine
1
1991
12
0.010
Why?
Genetic Testing
1
1992
52
0.010
Why?
Polymorphism, Restriction Fragment Length
1
1991
5
0.010
Why?
Chromosome Banding
1
1991
1
0.010
Why?
Karyotyping
1
1991
8
0.010
Why?
Chromosome Mapping
1
1991
26
0.010
Why?
Pleural Effusion
1
1991
12
0.010
Why?
Alleles
1
1991
201
0.010
Why?
DNA Probes
1
1990
7
0.010
Why?
Dexamethasone
1
1990
32
0.010
Why?
Hormones, Ectopic
1
1990
1
0.010
Why?
Paraneoplastic Endocrine Syndromes
1
1990
1
0.010
Why?
Child
1
1994
1235
0.010
Why?
Antibodies, Neoplasm
1
1990
13
0.010
Why?
Carbohydrate Conformation
1
1989
7
0.010
Why?
Body Fluids
1
1990
15
0.010
Why?
Leucine
1
1988
11
0.010
Why?
Phosphopyruvate Hydratase
1
1988
12
0.010
Why?
Peptide Biosynthesis
1
1988
1
0.010
Why?
Carcinoid Tumor
1
1988
5
0.010
Why?
Type C Phospholipases
1
1988
8
0.000
Why?
Cytoplasm
1
1988
30
0.000
Why?
Cell Communication
1
1988
23
0.000
Why?
Receptor, Insulin
1
1988
1
0.000
Why?
Receptors, Somatomedin
1
1988
4
0.000
Why?
Immunoglobulin Isotypes
1
1987
3
0.000
Why?
Immunization
1
1987
16
0.000
Why?
Immunoglobulin M
1
1987
14
0.000
Why?
Fluorescent Antibody Technique
1
1987
55
0.000
Why?
Whole-Body Counting
1
1987
2
0.000
Why?
Lymphatic System
1
1987
4
0.000
Why?
Drug Carriers
1
1987
6
0.000
Why?
Mycosis Fungoides
1
1987
6
0.000
Why?
P Blood-Group System
1
1986
1
0.000
Why?
Gangliosides
1
1986
6
0.000
Why?
ABO Blood-Group System
1
1986
5
0.000
Why?
Kinetics
1
1987
166
0.000
Why?
Melanoma
1
1987
48
0.000
Why?
Cell Separation
1
1986
26
0.000
Why?
Cell Cycle
1
1986
33
0.000
Why?
Cytogenetics
1
1986
2
0.000
Why?
Flow Cytometry
1
1986
109
0.000
Why?
Postoperative Complications
1
1992
868
0.000
Why?
Binding, Competitive
1
1985
22
0.000
Why?
Genes, MHC Class II
1
1985
1
0.000
Why?
Interferons
1
1985
8
0.000
Why?
HLA-B Antigens
1
1985
9
0.000
Why?
HLA-A Antigens
1
1985
13
0.000
Why?
HLA-C Antigens
1
1985
10
0.000
Why?
Peroxidase
1
1985
16
0.000
Why?
Peroxidases
1
1985
7
0.000
Why?
Clone Cells
1
1985
12
0.000
Why?
Rats, Inbred Strains
1
1984
16
0.000
Why?
Aging
1
1992
1537
0.000
Why?
Mulshine's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (708)
Explore
_
Co-Authors (1)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_